• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Boston Scientific (NY: BSX )

    84.54 +0.92 (+1.10%)
    Streaming Delayed Price Updated: 2:01 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,746,128
    Open 83.65
    Bid (Size) 84.53 (7)
    Ask (Size) 84.55 (7)
    Prev. Close 83.62
    Today's Range 83.55 - 85.24
    52wk Range 50.84 - 88.79
    Shares Outstanding 1,423,852,648
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why is Boston Scientific Stock Trading Lower On Wednesday?
    Boston Scientific's ACURATE IDE trial results showed a 16.16% composite rate for mortality, stroke, or rehospitalization, not meeting non-inferiority versus controls. 
    Via Benzinga
    $1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today
    Via Benzinga

    Performance

    YTD
    +46.16%
    +46.16%
    1 Month
    N/A
    N/A
    3 Month
    +15.87%
    +15.87%
    6 Month
    +16.53%
    +16.53%
    1 Year
    +60.08%
    +60.08%

    More News

    Read More
    Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
    Via Investor's Business Daily
    Boston Scientific Pauses Enrollment In Farapulse Study In Drug-Naive Patients With Irregular Heart Rhythm
    Via Benzinga
    Behind the Scenes of Boston Scientific's Latest Options Trends
    Via Benzinga
    Boston Scientific Earnings, Sales Top Q3 Views; Stock Eyes High
    Via Investor's Business Daily
    Boston Scientific's Options Frenzy: What You Need to Know
    Via Benzinga
    Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday?
    Via Benzinga
    Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual Forecast On Strong Demand For Heart Devices
    Via Benzinga
    Critical Insights From Boston Scientific Analyst Ratings: What You Need To Know
    Via Benzinga
    Key Takeaways From Boston Scientific Analyst Ratings
    Via Benzinga
    Performance Comparison: Boston Scientific And Competitors In Health Care Equipment & Supplies Industry
    Via Benzinga
    Is BOSTON SCIENTIFIC CORP Ready to Break Out of Its Range?
    Via Chartmill
    US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene
    Via Benzinga
    This Boston Scientific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
    Via Benzinga
    Solventum Stock Earns 81 RS Rating
    Via Investor's Business Daily
    Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
    Via Benzinga
    18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker'
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,100 Today
    Via Benzinga
    Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
    Via MarketBeat
    Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
    Via Benzinga
    Medtronic Stock: Growth On Rise of the Cardiovascular Machines
    Via MarketBeat
    Growth At Any Price (GAAP) Is A Bad Strategy. Valuation Matters.
    Via Talk Markets
    Spotlight on Boston Scientific: Analyzing the Surge in Options Activity
    Via Benzinga
    This Is Great News for Medtronic, but Is It Time to Buy the Stock?
    Via The Motley Fool
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.